Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Healthtrust
Fish and Richardson
McKinsey
Deloitte
Chubb
Express Scripts
McKesson
Colorcon

Generated: May 24, 2018

DrugPatentWatch Database Preview

NEO-DELTA-CORTEF Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Neo-delta-cortef, and when can generic versions of Neo-delta-cortef launch?

Neo-delta-cortef is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in NEO-DELTA-CORTEF is neomycin sulfate; prednisolone acetate. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; prednisolone acetate profile page.
Summary for NEO-DELTA-CORTEF
Drug patent expirations by year for NEO-DELTA-CORTEF

US Patents and Regulatory Information for NEO-DELTA-CORTEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn NEO-DELTA-CORTEF neomycin sulfate; prednisolone acetate OINTMENT;OPHTHALMIC 061039-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn NEO-DELTA-CORTEF neomycin sulfate; prednisolone acetate OINTMENT;OPHTHALMIC 061039-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn NEO-DELTA-CORTEF neomycin sulfate; prednisolone acetate SUSPENSION/DROPS;OPHTHALMIC 061037-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
QuintilesIMS
McKinsey
Healthtrust
Teva
Deloitte
Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.